When Nothing Else Works: Therapy Approved by FDA for Treatment-resistant Depression

Newswise - Millions of patients with treatment-resistant clinical depression, who have struggled for years with disability and how to cope with their condition, now have an option that could help them lead more productive and successful lives. The NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy system, developed by Neuronetics, Inc. and initiated by research at the Medical University of South Carolina (MUSC), is the first and only approved TMS Therapy® device cleared by the Food and Drug Administration for the treatment of severe depression (Oct. 7). Patients must be adults with major depressive disorder, commonly known as treatment-resistant depression, who have failed to improve their condition with other treatments or medication. MUSC currently is the only location in South Carolina, North Carolina, Virginia,... [read full story]